Los Angeles Capital Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Los Angeles Capital Management's MXCT Position: Q1 2026 in Review
Los Angeles Capital Management held its MaxCyte (MXCT) position steady in Q1 2026 at 63,330 shares worth $44.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.
Los Angeles Capital Management first reported a position in MXCT in Q4 2021 and has held it in 5 quarters since. The position peaked at $349K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Los Angeles Capital Management held 63,330 shares of MaxCyte worth $44.5K as of Q1 2026.
- Los Angeles Capital Management left its MaxCyte share count unchanged in Q1 2026.
- MaxCyte made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1519 holding.
- Los Angeles Capital Management first reported a position in MaxCyte in Q4 2021 and has held it in 5 quarters since.
- Los Angeles Capital Management's MaxCyte position peaked at $349K in Q4 2021.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.